Suppr超能文献

日本手掌足底角化症管理指南。

Japanese guidelines for the management of palmoplantar keratoderma.

机构信息

Department of Clinical Pharmacology, Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Japan.

Department of Dermatology, Keio University Graduate School of Medicine, Tokyo, Japan.

出版信息

J Dermatol. 2021 Aug;48(8):e353-e367. doi: 10.1111/1346-8138.15850. Epub 2021 Jun 13.

Abstract

Palmoplantar keratoderma (PPK) is a collective term for keratinizing disorders in which the main clinical symptom is hyperkeratosis on the palms and soles. To establish the first Japanese guidelines approved by the Japanese Dermatological Association for the management of PPKs, the Committee for the Management of PPKs was founded as part of the Study Group for Rare Intractable Diseases. These guidelines aim to provide current information for the management of PPKs in Japan. Based on evidence, they summarize the clinical manifestations, pathophysiologies, diagnostic criteria, disease severity determination criteria, treatment, and treatment recommendations. Because of the rarity of PPKs, there are only few clinical studies with a high degree of evidence. Therefore, several parts of these guidelines were established based on the opinions of the committee. To further optimize the guidelines, periodic revision in line with new evidence is necessary.

摘要

掌跖角化病(PPK)是一组角化障碍性疾病的统称,其主要临床症状是手掌和足底的过度角化。为了制定日本皮肤科协会批准的首个日本 PPK 管理指南,作为罕见疑难病研究组的一部分,成立了 PPK 管理委员会。这些指南旨在为日本 PPK 的管理提供当前信息。它们基于证据,总结了 PPK 的临床表现、病理生理学、诊断标准、疾病严重程度确定标准、治疗和治疗建议。由于 PPK 较为罕见,因此仅有少数具有高度证据的临床研究。因此,这些指南的几个部分是基于委员会的意见制定的。为了进一步优化指南,有必要根据新证据定期修订。

相似文献

1
Japanese guidelines for the management of palmoplantar keratoderma.
J Dermatol. 2021 Aug;48(8):e353-e367. doi: 10.1111/1346-8138.15850. Epub 2021 Jun 13.
2
Hereditary palmoplantar keratodermas. Part I. Non-syndromic palmoplantar keratodermas: classification, clinical and genetic features.
J Eur Acad Dermatol Venereol. 2018 May;32(5):704-719. doi: 10.1111/jdv.14902. Epub 2018 Mar 24.
3
Acquired palmoplantar keratoderma.
Am J Clin Dermatol. 2007;8(1):1-11. doi: 10.2165/00128071-200708010-00001.
4
Hereditary palmoplantar keratodermas. Part II: syndromic palmoplantar keratodermas - Diagnostic algorithm and principles of therapy.
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):899-925. doi: 10.1111/jdv.14834. Epub 2018 Mar 25.
5
Palmoplantar keratoderma (PPK): acquired and genetic causes of a not so rare disease.
J Dtsch Dermatol Ges. 2014 Sep;12(9):781-8. doi: 10.1111/ddg.12418.
6
Drugs Associated With the Development of Palmoplantar Keratoderma: A Systematic Review.
J Cutan Med Surg. 2021 Sep;25(5):553-554. doi: 10.1177/12034754211004560. Epub 2021 Mar 28.
7
[Nagashima-type palmoplantar keratoderma: A little-known palmoplantar keratoderma in Europe].
Ann Dermatol Venereol. 2019 Feb;146(2):125-130. doi: 10.1016/j.annder.2018.11.005. Epub 2018 Dec 21.
8
[Genetics of complex and syndromic palmoplantar keratoderma].
Ann Biol Clin (Paris). 2021 Dec 1;79(6):551-565. doi: 10.1684/abc.2021.1688.
9
Palmoplantar Keratoderma with Keratoconus.
Middle East Afr J Ophthalmol. 2018 Jan-Mar;25(1):49-51. doi: 10.4103/meajo.MEAJO_221_17.
10
Pain mechanisms in hereditary palmoplantar keratodermas.
Br J Dermatol. 2020 Mar;182(3):543-551. doi: 10.1111/bjd.17880. Epub 2019 Jul 24.

引用本文的文献

1
A case report of palmoplantar keratoderma in a 3-year-old girl: A structured approach in primary care settings.
Malays Fam Physician. 2025 Jul 9;20:42. doi: 10.51866/cr.668. eCollection 2025.
2
Atypical Mal de Meleda in a Hispanic Patient.
Case Rep Dermatol Med. 2023 Sep 14;2023:6640311. doi: 10.1155/2023/6640311. eCollection 2023.
3
Dimethyl fumarate for treating Papillon-Lefèvre syndrome.
JAAD Case Rep. 2022 Nov 8;31:19-22. doi: 10.1016/j.jdcr.2022.11.003. eCollection 2023 Jan.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验